STEPHANIE JUAREZ: Open Payments
NPI 1952813735 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 59 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,088 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $341 |
| AstraZeneca Pharmaceuticals LP | 10 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $169 |
| Lilly USA, LLC | 12 | $140 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: Kerendia, BREZTRI, MOUNJARO, Wegovy, Ozempic, AIRSUPRA, JARDIANCE, FARXIGA.
Industry payments across TX — which companies pay providers there.
